Change Text Size
Your Retirement Living Connection
Home 
Senior Living Retirement Living Upcoming eldercare event in Massachusetts
Senior Living Retirement Living Upcoming eldercare event in Massachusetts
Upcoming eldercare event in Massachusetts |
 |
 |
 |
| Written by Francis Ma |
| Thursday, 19 November 2009 12:04 |
|
A Massachusetts State senator will host a senior health and wellness fair at a retirement living facility in Framingham in late November. On November 21, Senator Karen Spilka will invite visitors to a fair that was organized specifically for seniors, reports the MetroWest Daily News. The event will include workshops, exhibits and free health screenings.  It will take place at the Callahan Senior Center, beginning at 9 a.m. and ending at 1 p.m.Representatives from the MetroWest Homecare and Hospice will also be in attendance, says the news source. The organization has provided its services to thousands of elderly people this year and claims it can save seniors money by treating them at home. Spilka says that caring for seniors in their homes can be less expensive than other alternatives, and can contribute to the happiness of these men and women, according to the publication. The U.S. Census Bureau says that 13.4 percent of the population in Massachusetts was over the age of 65 in 2008. Last year, about 6.5 million people lived in the Bay State. © Copyright |
Related Articles
Cancer drug may be used to treat Alzheimer's disease
Thursday, September 2, 2010
Researchers in the United States recently announced that a drug used to treat a certain type of cancer may be able to treat Alzheimer's disease. Reuters reports that the drug has shown potential in reducing the appearance of amyeloid plaques - one of the main causes of the mental illness.
According to the news source, the study revealed that Gleevack, which is a pill that is given to chronic myeloid leukemia patients, was able to block gamma-secretase activating protein, which can halt the production of the plaques.
"Our findings reveal that gamma-secretase activating protein is a potential target for a new class of anti-amyloid therapies," Paul Greengard, one of the researchers, told the news provider.
Read more...
According to the news source, the study revealed that Gleevack, which is a pill that is given to chronic myeloid leukemia patients, was able to block gamma-secretase activating protein, which can halt the production of the plaques.
"Our findings reveal that gamma-secretase activating protein is a potential target for a new class of anti-amyloid therapies," Paul Greengard, one of the researchers, told the news provider.
Read more...
Moderate exercise can help prevent cognitive decline
Wednesday, September 1, 2010
The physical benefits of exercise are widely known, but new research shows that even moderate activity can help improve brain function in senior citizens. SeniorJournal.com reports the study, which was published in Frontiers in Aging Neuroscience, found that walking 40 minutes a day, three days a week can significantly improve the connectivity of brain circuits.
According to the news source, the participants in the study were between 59 and 80 years old and were leading a sedentary lifestyle before the data was compiled.
Read more...
According to the news source, the participants in the study were between 59 and 80 years old and were leading a sedentary lifestyle before the data was compiled.
Read more...
Study finds rheumatoid arthritis may lower chances of Alzheimer's
Tuesday, August 31, 2010
Results of a new study recently published in the Journal of Alzheimer's Disease suggests a link between rheumatoid arthritis and a reduced risk of developing Alzheimer's disease. The Los Angeles Times reports the research found that a protein released in those who have arthritis may attack amyoloid deposits in the brain, which is one of the main causes of the mental illness.
According to the news source, the study was conducted by injecting two groups of mice with the protein, with one group altered to have memory problems and the other comprised of naturally old rodents.
Read more...
According to the news source, the study was conducted by injecting two groups of mice with the protein, with one group altered to have memory problems and the other comprised of naturally old rodents.
Read more...
Comments (0)